AI assistant
INOVIO PHARMACEUTICALS, INC. — Director's Dealing 2021
Jun 11, 2021
34008_dirs_2021-06-11_3904ee11-8971-4922-b090-ed0907f2438f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INOVIO PHARMACEUTICALS, INC. (INO)
CIK: 0001055726
Period of Report: 2021-06-09
Reporting Person: Shea Jacqueline Elizabeth (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-09 | Common Stock | S | 38535 | $10.01 | Disposed | 21592 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2: These transactions were executed in multiple trades at prices ranging from $10.00 to $10.06, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.